Invention Grant
US08461178B2 Naphthyridine derivatives and the use thereof as kinase inhibitors
有权
萘啶衍生物及其作为激酶抑制剂的用途
- Patent Title: Naphthyridine derivatives and the use thereof as kinase inhibitors
- Patent Title (中): 萘啶衍生物及其作为激酶抑制剂的用途
-
Application No.: US12953680Application Date: 2010-11-24
-
Publication No.: US08461178B2Publication Date: 2013-06-11
- Inventor: Tilmann Schuster , Matthias Gerlach , Irene Seipelt , Emmanuel Polymeropoulos , Gilbert Mueller , Eckhard Guenther , Pascal Marchand , Julien Defaux
- Applicant: Tilmann Schuster , Matthias Gerlach , Irene Seipelt , Emmanuel Polymeropoulos , Gilbert Mueller , Eckhard Guenther , Pascal Marchand , Julien Defaux
- Applicant Address: DE Frankfurt
- Assignee: Aeterna Zentaris GmbH
- Current Assignee: Aeterna Zentaris GmbH
- Current Assignee Address: DE Frankfurt
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP09177132 20091126
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D471/02
Abstract:
The present invention relates to kinase modulators of the naphthyridine type and to the preparation and use thereof as medicaments for the modulation of misdirected cellular signal transduction processes, in particular for influencing the function of tyrosine and serine/threonine kinases and for the treatment of malignant or benign tumors and other disorders based on pathological cell proliferation, such as, for example, restenosis, psoriasis, arteriosclerosis and cirrhosis of the liver.
Public/Granted literature
- US20110150831A1 NOVEL NAPHTHYRIDINE DERIVATIVES AND THE USE THEREOF AS KINASE INHIBITORS Public/Granted day:2011-06-23
Information query
